InShapeMD’s Innovative Semaglutide Program Tackles Diabetes and Weight Loss Together In Texas
San Angelo, TX, 22nd October 2024, ZEX PR WIRE, Obesity and diabetes often go hand-in-hand, creating a vicious cycle that can significantly impact a person’s health and quality of life. InShapeMD San Angelo is proud to offer a groundbreaking solution: our Semaglutide program. This innovative treatment combines the power of medication with personalized support to help individuals address both obesity and diabetes effectively.
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, works by mimicking the body’s natural hormone that regulates appetite and blood sugar levels. By stimulating the release of insulin and slowing down the emptying of the stomach, Semaglutide helps individuals feel fuller for longer, reducing cravings and promoting weight loss. Additionally, it improves blo...